ArticleJournal of translational medicine2024

Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective study.

Weihao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.